DE3674525D1 - Peptidderivate mit lactonischer oder zykloamidischer struktur, deren verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. - Google Patents
Peptidderivate mit lactonischer oder zykloamidischer struktur, deren verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.Info
- Publication number
- DE3674525D1 DE3674525D1 DE8686401738T DE3674525T DE3674525D1 DE 3674525 D1 DE3674525 D1 DE 3674525D1 DE 8686401738 T DE8686401738 T DE 8686401738T DE 3674525 T DE3674525 T DE 3674525T DE 3674525 D1 DE3674525 D1 DE 3674525D1
- Authority
- DE
- Germany
- Prior art keywords
- pharmaceutical compositions
- same
- compositions containing
- cycloamidic
- lactonic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 abstract 1
- IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940095074 cyclic amp Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 150000002596 lactones Chemical class 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8511936A FR2585709B1 (fr) | 1985-08-05 | 1985-08-05 | Nouveaux derives peptidiques a structure lactonique ou cycloamidique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3674525D1 true DE3674525D1 (de) | 1990-10-31 |
Family
ID=9321967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE8686401738T Expired - Lifetime DE3674525D1 (de) | 1985-08-05 | 1986-08-04 | Peptidderivate mit lactonischer oder zykloamidischer struktur, deren verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4725581A (enExample) |
| EP (1) | EP0217688B1 (enExample) |
| JP (2) | JPS6233198A (enExample) |
| AT (1) | ATE56976T1 (enExample) |
| AU (1) | AU581599B2 (enExample) |
| CA (1) | CA1276397C (enExample) |
| DE (1) | DE3674525D1 (enExample) |
| DK (1) | DK364786A (enExample) |
| ES (1) | ES2000128A6 (enExample) |
| FR (1) | FR2585709B1 (enExample) |
| GR (1) | GR862059B (enExample) |
| IE (1) | IE58541B1 (enExample) |
| NZ (1) | NZ217079A (enExample) |
| PT (1) | PT83145B (enExample) |
| ZA (1) | ZA865826B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0696575B2 (ja) * | 1987-09-17 | 1994-11-30 | 三菱化成株式会社 | ４−アミノピリジン誘導体及びその酸付加塩 |
| GB2227658A (en) * | 1989-02-03 | 1990-08-08 | Cellana | Thyrotropin releasing hormone (trh) composition for enhancing immune function |
| FR2649110B1 (fr) * | 1989-06-29 | 1994-10-21 | Adir | Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2663336B1 (fr) * | 1990-06-18 | 1992-09-04 | Adir | Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| US5504071A (en) * | 1990-10-03 | 1996-04-02 | Polifarma S.P.A. | Compounds with a sequence of three radicals, the central one being α-a |
| IT1242002B (it) * | 1990-10-03 | 1994-02-02 | Polifarma Spa | Composti con attivita' farmacologica antiipertensiva, analgesica, immunomodulante e antiinfiammatoria, che presentano nella molecola una sequenza di tre radicali, essendo alfa-amminoacido quello centrale |
| FR2694295B1 (fr) * | 1992-07-28 | 1994-09-02 | Adir | Nouveaux peptides dérivés de trifluoromethylcetones, leur procéde de préparation et les compositions pharmaceutiques qui les contiennent. |
| AU1757597A (en) * | 1996-02-05 | 1997-08-22 | Eli Lilly And Company | Method of treating beta-amyloid peptide associated conditions using trh |
| DE19616509A1 (de) * | 1996-04-25 | 1998-01-15 | Asta Medica Ag | Neue spezifische Immunophilin-Liganden als Antiasthmatika, Immunsuppressiva |
| BR0308118A (pt) * | 2002-03-01 | 2005-01-11 | Warner Lambert Co | Método para o tratamento de osteoartrite |
| US7628342B2 (en) | 2004-05-11 | 2009-12-08 | Daiwa Can Company | Liquefied gas dispensing nozzle and liquefied gas dispensing apparatus |
| WO2007089616A2 (en) | 2006-01-26 | 2007-08-09 | The University Of Rochester | Inhibiting amyloid-beta peptide/rage interaction at the blood-brain barrier |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5944308B2 (ja) * | 1976-03-23 | 1984-10-29 | 武田薬品工業株式会社 | ペプタイド |
| US4260601A (en) * | 1979-10-23 | 1981-04-07 | Nyegaard & Co. A/S | Chemical compounds |
| US4293481A (en) * | 1980-07-24 | 1981-10-06 | E. R. Squibb & Sons, Inc. | Tripeptide inhibitors of angiotensin-converting enzyme |
| JPS57188526A (en) * | 1981-05-14 | 1982-11-19 | Takeda Chem Ind Ltd | Peptide-containing pharmaceutical preparation |
| US4499079A (en) * | 1982-11-18 | 1985-02-12 | E. R. Squibb & Sons, Inc. | Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides |
| DE3332633A1 (de) * | 1983-09-09 | 1985-04-04 | Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München | Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel |
-
1985
- 1985-08-05 FR FR8511936A patent/FR2585709B1/fr not_active Expired
-
1986
- 1986-07-31 DK DK364786A patent/DK364786A/da not_active Application Discontinuation
- 1986-08-01 US US06/892,345 patent/US4725581A/en not_active Expired - Fee Related
- 1986-08-04 CA CA000515267A patent/CA1276397C/fr not_active Expired - Lifetime
- 1986-08-04 AT AT86401738T patent/ATE56976T1/de not_active IP Right Cessation
- 1986-08-04 GR GR862059A patent/GR862059B/el unknown
- 1986-08-04 EP EP86401738A patent/EP0217688B1/fr not_active Expired - Lifetime
- 1986-08-04 AU AU60812/86A patent/AU581599B2/en not_active Ceased
- 1986-08-04 ES ES8600846A patent/ES2000128A6/es not_active Expired
- 1986-08-04 DE DE8686401738T patent/DE3674525D1/de not_active Expired - Lifetime
- 1986-08-04 ZA ZA865826A patent/ZA865826B/xx unknown
- 1986-08-04 NZ NZ217079A patent/NZ217079A/en unknown
- 1986-08-05 PT PT83145A patent/PT83145B/pt not_active IP Right Cessation
- 1986-08-05 IE IE208586A patent/IE58541B1/en not_active IP Right Cessation
- 1986-08-05 JP JP61184117A patent/JPS6233198A/ja active Granted
-
1989
- 1989-01-05 JP JP64000815A patent/JPH01230597A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| NZ217079A (en) | 1988-05-30 |
| GR862059B (en) | 1986-12-24 |
| EP0217688A1 (fr) | 1987-04-08 |
| EP0217688B1 (fr) | 1990-09-26 |
| JPH0229680B2 (enExample) | 1990-07-02 |
| JPH01230597A (ja) | 1989-09-14 |
| FR2585709B1 (fr) | 1987-10-02 |
| DK364786D0 (da) | 1986-07-31 |
| AU6081286A (en) | 1987-02-12 |
| JPS6233198A (ja) | 1987-02-13 |
| ATE56976T1 (de) | 1990-10-15 |
| ZA865826B (en) | 1987-04-29 |
| IE58541B1 (en) | 1993-10-06 |
| AU581599B2 (en) | 1989-02-23 |
| DK364786A (da) | 1987-02-06 |
| PT83145A (fr) | 1986-09-01 |
| JPH0259160B2 (enExample) | 1990-12-11 |
| CA1276397C (fr) | 1990-11-13 |
| US4725581A (en) | 1988-02-16 |
| FR2585709A1 (fr) | 1987-02-06 |
| PT83145B (pt) | 1989-03-30 |
| ES2000128A6 (es) | 1987-12-16 |
| IE862085L (en) | 1987-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3856580D1 (de) | Verfahren und Desoxyribonukleinsäure zur Herstellung von Gewebefaktor-Protein | |
| IT1147087B (it) | Nuovi preparati farmaceutici per il trattamento dei disordini del sistema nervoso centrale e procedimento per la loro preparazione | |
| DE3674525D1 (de) | Peptidderivate mit lactonischer oder zykloamidischer struktur, deren verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| DE68908971D1 (de) | Verwendung von physiologisch wirksamen Substanzen zur Herstellung von Medikamenten für Gehirn- und Nervenerkrankungen. | |
| NO173726C (no) | Fremgangsmaate for fremstilling av et oralt terapeutisk system for administrering av karbamazpin | |
| ES542296A0 (es) | Metodo para la preparacion del factor viii humano funcional | |
| DE68903442D1 (de) | Feste und poroese einheitsform, enthaltend mikropartikel und/oder nanopartikel und verfahren zu ihrer herstellung. | |
| GEP20084347B (en) | New derivatives of diphosphonic acid, method for their preparation and medicamentous form containing them | |
| ATE74768T1 (de) | Feste pharmazeutische zubereitung und verfahren zur herstellung derselben. | |
| FR2537130B1 (fr) | Derives d'acides b-hydroxybutyriques, leur procede de preparation et leur application a la preparation de l-carnitine | |
| ATA66576A (de) | Verfahren zur herstellung von 1-acylamino- methyl-1,2,3,4-tetrahydroisochinolinderivaten, ihren racematen, optischen isomeren und physiologisch unbedenklichen saeureadditions- salzen | |
| IT8721115A0 (it) | Fitopreparato per la cura di affezioni cutanee. | |
| FR2340311A1 (fr) | Nouveaux derives de la piperazine, convenant entre autres pour le traitement d'affections coronaires, et procede pour leur preparation | |
| FR2633619B1 (fr) | Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant | |
| DE3679947D1 (de) | Halbleiteranordnungen und verfahren zur herstellung mittels ionenimplantation. | |
| FI874450A7 (fi) | Farmaseuttiset valmisteet alkuperältään toiminnallisten ja elimelliste n aivohäiriöiden hoitamiseen. | |
| AT381092B (de) | Verfahren zur herstellung von neuen substituierten pyrrolo-(2,1-b)-chinazolinen und pyrido(2,1-b)- chinazolinen, ihren isomeren und deren gemischen und ihren pharmazeutisch unbedenklichen salzen | |
| JPS5753475A (en) | Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same | |
| FR2575158B1 (fr) | Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central | |
| FI853229L (fi) | Nya benzodiazepiner, foerfarande foer deras framstaellning och deras anvaendning. | |
| IT1200609B (it) | Composizione farmaceutice per il trattamento delle turbe cerebrovascolari e del cervello anziano | |
| Juhász | Hungarian EEG society: Debrecen, December 18 and 19, 1961 | |
| ATE56360T1 (de) | Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma. | |
| HU895239D0 (en) | Process for the preparation of pharmaceutical compositions suitable for the treatment of skin diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |